Biotech · Private company
XOMA (US) LLC
Track this companyFree. Adds XOMA (US) LLC to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- XOMA 358 multiple dose level 1Phase 2 · HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- XOMA 358 single dose level APhase 2 · HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- XOMA 358 single dose level BPhase 2 · HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
- XOMA 358 single dose level CPhase 2 · HypoglycemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass SurgeryPHASE2 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02772718 · fetched Nov 12, 2026
- Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior TherapiesPHASE1_PHASE2 · COMPLETED · started Mar 1, 2008ClinicalTrials.gov NCT00670592 · fetched Nov 12, 2026